APA
ONCY

American Portfolios Advisors’s Oncolytics Biotech ONCY Stock Holding History

American Portfolios Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-105
Closed -$195 – 2774
2019
Q1 		$195 Hold
105
– – ﹤0.01% 2568
2018
Q4 		$193 Hold
105
– – ﹤0.01% 2351
2018
Q3 		$403 Hold
105
– – ﹤0.01% 2352
2018
Q2 		$563 Buy
+105
New +$646 ﹤0.01% 2311

Other funds holding ONCY

Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

American Portfolios Advisors's ONCY Position: Q2 2019 in Review

American Portfolios Advisors sold out of Oncolytics Biotech (ONCY) in Q2 2019, closing a stake of 105 shares — an estimated $195 sold.

American Portfolios Advisors first reported a position in ONCY in Q2 2018 and held it in 4 quarters. The position peaked at $563 in Q2 2018. 20 funds tracked by Wall St. Rank hold ONCY as of Q2 2019.

  • American Portfolios Advisors reported no remaining Oncolytics Biotech position as of Q2 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 105 Oncolytics Biotech shares in Q2 2019, an estimated $195.
  • American Portfolios Advisors first reported a position in Oncolytics Biotech in Q2 2018 and held it in 4 quarters.
  • American Portfolios Advisors's Oncolytics Biotech position peaked at $563 in Q2 2018.
  • 20 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2019.

Based on American Portfolios Advisors's 13F filing for Q2 2019, filed 24 Mar 2023.